Search Login Register

U 0126 (UO 126) Summary

Description: inhibits both ERK and mitogen-activated protein kinase kinase (MAPKK); structure in first source

Also Known As: UO 126; 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene; U-0126; U0126; U0126 cpd Show All >>

Networked: 513 relevant articles (20 outcomes, 31 trials/studies) for this Bio-Agent

Key Diseases for which U 0126 is Relevant

  1. Neoplasms (Cancer) : 2 outcomes 4 studies in 63 results
  2. Brain Ischemia (Cerebral Ischemia) : 2 outcomes 2 studies in 10 results
  3. Anoxia (Hypoxia) : 2 outcomes 1 study in 43 results
  4. Hyperalgesia : 1 outcome 2 studies in 29 results
  5. Pancreatic Neoplasms (Pancreatic Cancer) : 1 outcome 2 studies in 12 results
Show All >>

Drugs Related to U 0126

  1. Phosphotransferases (Kinase)
  2. Estrogens (Estrogen)
  3. Protein Kinases (Protein Kinase)
  4. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
  5. Mitogen-Activated Protein Kinase 3
  6. PD 98059
  7. Proteins (Proteins, Gene)
  8. Butadienes
  9. Caspase 3 (Caspase-3)
  10. MAP Kinase Kinase 1
Show All >>

Therapies Related to U 0126

  1. Spinal Injections
  2. Heterologous Transplantation (Xenotransplantation)
  3. Acupuncture Points (Acupuncture Point)
  4. Ligation
  5. Drug Therapy (Chemotherapy)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.